Vivesto AB (OASMY)
0.0499
0.00 (0.00%)
USD |
OTCM |
May 31, 16:00
Vivesto Net Income (Quarterly): -0.8119M for March 31, 2024
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | -0.8119M |
December 31, 2023 | -6.061M |
September 30, 2023 | -1.463M |
June 30, 2023 | -2.681M |
March 31, 2023 | -1.956M |
December 31, 2022 | -20.59M |
September 30, 2022 | -6.837M |
June 30, 2022 | -3.936M |
March 31, 2022 | -2.840M |
December 31, 2021 | -0.3226M |
September 30, 2021 | -3.588M |
June 30, 2021 | -6.862M |
March 31, 2021 | -4.922M |
October 31, 2020 | -6.091M |
July 31, 2020 | -5.686M |
April 30, 2020 | 10.93M |
January 31, 2020 | -6.227M |
October 31, 2019 | -1.887M |
July 31, 2019 | -4.202M |
April 30, 2019 | -8.509M |
January 31, 2019 | -3.356M |
October 31, 2018 | -6.760M |
July 31, 2018 | -3.539M |
April 30, 2018 | -3.900M |
January 31, 2018 | -3.52M |
Date | Value |
---|---|
October 31, 2017 | -3.101M |
July 31, 2017 | -3.687M |
April 30, 2017 | -4.717M |
January 31, 2017 | -4.385M |
October 31, 2016 | -4.813M |
July 31, 2016 | -4.422M |
April 30, 2016 | -3.965M |
January 31, 2016 | -2.959M |
October 31, 2015 | -5.156M |
July 31, 2015 | -4.750M |
April 30, 2015 | -3.534M |
January 31, 2015 | -3.592M |
October 31, 2014 | -3.772M |
July 31, 2014 | -4.930M |
April 30, 2014 | -5.828M |
January 31, 2014 | -4.660M |
October 31, 2013 | -2.883M |
July 31, 2013 | -2.762M |
April 30, 2013 | -3.568M |
January 31, 2013 | -2.358M |
October 31, 2012 | -2.194M |
July 31, 2012 | -2.752M |
April 30, 2012 | -2.943M |
January 31, 2012 | -2.528M |
October 31, 2011 | -2.048M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Quarterly) Range, Past 5 Years
-20.59M
Minimum
Dec 2022
10.93M
Maximum
Apr 2020
-4.002M
Average
-3.936M
Median
Jun 2022
Net Income (Quarterly) Benchmarks
Abliva AB | -1.753M |
Karolinska Development AB | 0.0201M |
Calliditas Therapeutics AB | -23.73M |
Oncopeptides AB | -3.758M |
Olink Holding AB | -16.06M |
Net Income (Quarterly) Related Metrics
Total Expenses (Quarterly) | 0.8976M |
EPS Diluted (Quarterly) | -0.0058 |
Enterprise Value | 3.278M |
Earnings Yield | -124.9% |
Normalized Earnings Yield | -168.19 |